PR
PROCEPT BioRobotics
PRCT · NASDAQ
$22.76 +7.41% (+$1.57)
1M +4.84%
Market Cap $1.30B
P/E Ratio -
Div. Yield -
ROE 30.62%
Piotroski F-Score Weak
2/9Valuation
50 /100
Fair P/B 3.81x
P/S 3.84x
EV/EBITDA N/A
Growth
100 /100
Growing Book val. growth 22.90%
Rev. growth 60.14%
FCF growth N/A
Profitability
20 /100
Weak Net margin 32.54%
Op. margin 33.86%
FCF margin 37.34%
Quality
9 /100
Poor ROE 30.62%
ROA 22.90%
Asset turnover 0.70x
Debt
69 /100
Low Current ratio 6.55x
Int. coverage -30.52x
Debt/Equity 0.23x
Stability
68 /100
Stable Rev. volatility 22.39%
EPS volatility 18.12%
Profitable years 0
Bulios Scoring opisuje jakość i historię firmy, a nie przyszły zwrot. Wysoki wynik to nie sygnał zakupu. Dowiedz się więcej
Zapytaj StockBota o PRCT
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Larry L. Wood
Employees
888
Headquarters
San Jose
Nadchodzące wydarzenia
03 LIS
Earnings
Upcoming earnings report